Zura Bio Limited is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Sandeep C. Kulkarni, with a market cap of $562.6M.
Common questions about Zura Bio Limited
Zura Bio Limited is scheduled to report earnings for Q1 2026 on May 7, 2026.
Zura Bio Limited has approximately 15 employees.
We use cookies for analytics. See our Privacy and Cookie Policy.